BEIJING, Dec. 24 (Xinhua) -- China's top securities regulator has addressed recent online rumors about delisting of some companies, urging investors to rely on authoritative sources for information ...

02 研究发现，雷帕霉素-达沙替尼联合伊立替康-替莫唑胺可显著延长MYCN扩增型复发性神经母细胞瘤患者的无进展生存期 (PFS)和总体生存期 (OS)。